Hilary Reno, MD, PhD, Assistant Professor of Medicine at Washington University and Medical Director of the St. Louis County Sexual Health Clinic, describes the current US trends in chlamydia and gonorrhea infections, identifies causative agents for persistent and recurrent NGU and CDC treatment recommendation, discusses how to assess patients' needs for extragenital testing, and describes the process for self-collected testing and its advantages in clinical settings.
Supported by the Office of Population Affairs, US Dept of Health and Human Services Grant #5 FPTPA006029-02-00.
This brief webinar will describe the importance of including PrEP in family planning services, provide an overview of PrEP-related services and their costs, and introduce billing strategies and codes to cover PrEP-related services, including three practice scenarios.
Supported by the Department of Health & Human Services/Office of Population Affairs/Office of Family Planning
Grant #5 FPTPA006067-01-00.
Dr. Erika Thompson, PhD, MPH, CPH, Assistant Professor, Department of Health Behavior and Health Systems at the University of North Texas Health Science Center received her MPH in Epidemiology from the University of Florida and PhD in Public Health from the University of South Florida. Dr. Thompson completed a postdoctoral fellowship at the University of South Florida focusing on women's reproductive health and public health. Dr. Thompson will describe two studies that were conducted in Florida to better understand the knowledge and perceptions held by reproductive-age people about the Zika virus. Implications from these studies for provider-patient communication will also be discussed.
By the end of this presentation, participants will be able to:
Describe reproductive-age men and women's perspectives on preventing Zika through sexual transmission; and
Identify strategies for counseling reproductive-age persons on preventing Zika and Zika-related birth defects.
Supported by the Office of Population Affairs, US Dept of Health and Human Services Grant #1 FPTPA006029-01-00.